676 results on '"Velikova, G."'
Search Results
152. Quality of Life in a Randomised Double-Blind Phase III Trial of Cediranib (Azd2171) in Relapsed Platinum Sensitive Ovarian Cancer (Icon6)
153. Abstract P3-14-09: Should testing for estrogen receptor, progesterone receptor and HER2 be repeated following neoadjuvant chemotherapy?
154. Psychosocial supportive care services for haematopoietic stem cell transplant patients; a service evaluation of three UK transplant centres
155. Can individual patients assess differences in quality of life between groups of patients?
156. Lebensqualität von Patientinnen mit lokal fortgeschrittenem oder metastasiertem Brustkrebs nach Vorbehandlung mit Anthrazyklinen und Taxanen unter der Behandlung mit Eribulin oder Capecitabin: eine randomisierte, unverblindete Phase III-Studie
157. Abstract S3-3: The UK TACT2 Trial: comparison of standard vs accelerated epirubicin in patients requiring chemotherapy for early breast cancer (EBC) (CRUK/05/019)
158. Abstract P4-01-14: Can MRI predict the response to neoadjuvant chemotherapy in breast cancer accurately?
159. 15. How frequently is breast conservation possible after neoadjuvant chemotherapy in women with breast cancer – Overview of our surgical practice
160. Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey
161. PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30
162. Integrating cancer survivors' experiences into UK cancer registries: design and development of the ePOCS system (electronic Patient-reported Outcomes from Cancer Survivors)
163. The social difficulties of cancer patients of South Asian Indian and Pakistani origin: a cross-sectional questionnaire and interview study
164. Evaluation of expressive writing as an intervention for patients following a mastectomy for breast cancer – a feasibility study
165. Development of guidelines for the management of cancer related fatigue
166. Using the measure of patient centred communication to assess oncology consultations
167. COMPASS collaborative research Strand 2: The development and evaluation of complex interventions for psychological distress in cancer patients
168. Impact of information intervention on social distress; a randomised pilot study
169. Identifying patients psychological needs in oncology consultations: an exploration of rates of discussion and patterns of referral
170. Development of guidelines for oncologists to manage emotional distress in cancer patients
171. Abstract P5-10-07: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF in 129 UK Hospitals (CRUK/05/019)
172. Abstract P5-10-06: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) in 129 UK Hospitals (4391 Patients) (CRUK/05/019)
173. 94 Patient-reported outcomes in cancer research
174. Health-related quality of life (HRQOL) in non-small cell lung cancer (NSCLC): An update of a systematic review on methodological issues in randomized controlled trials (RCTs)
175. Quality of life in head and neck cancer: patient views on medical consultations
176. Randomized trial of quality-of-life measurement in oncology practice: Do oncologists need to know?
177. Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory
178. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
179. Clodronate compared to ibandronate breast cancer bone metastases patient preference study
180. O105 Individual assessment of quality of life: a communication tool for modern practice
181. Early Phase in the Development of a Bone Metastases Quality of Life Module
182. P88 MRC/EORTC (BIG 2–04) SUPREMO – a phase III trial assessing the role of chest wall irradiation in ‘intermediate-risk’ breast cancer
183. The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation
184. The initial development of an item bank to assess and screen for psychological distress in cancer patients
185. 198 Patients' and health care professionals' perspectives on the most important quality of life issues in bone metastases
186. Quality of Life and Symptom End Points in Palliative Bone Metastases Trials
187. Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale
188. Psychosocial difficulties, deprivation and cancer: three questionnaire studies involving 609 cancer patients
189. Health related quality of life outcomes in cancer clinical trials
190. Developing an item bank to measure psychological distress in cancerpatients using Rasch models
191. Breast cancer outcomes in South Asian population of West Yorkshire
192. 910 The level of reporting of health-related quality of life in cancer research. Evidence from 123 randomised controlled trials enrolling 36220 cancer patients
193. 1046P - Impact of Treatment with Eribulin (Eri) or Capecitabine (Cap) for Metastatic Breast Cancer (Mbc) on Eq–5D Utility Derived from Eortc Qlq–C30
194. 875O - Quality of Life in a Randomised Double-Blind Phase III Trial of Cediranib (Azd2171) in Relapsed Platinum Sensitive Ovarian Cancer (Icon6)
195. 392P - Health-Related Quality of Life (Hrqol) and Disease Symptoms in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (Mbc) Treated with Eribulin (Eri) or Capecitabine (Cap) in a Post Anthracycline and Taxane Setting
196. Computer-Administered Individual Quality of LD7E Assessments in Oncology Practice
197. Computer-based quality of life questionnaires may contribute to doctor–patient interactions in oncology
198. Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice
199. Quality of life instruments in oncology
200. Automated screening and recording of quality of life data: a feasibility study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.